In this Issue:
Analysis of RARP
Response to next-generation androgen receptor axis drugs
Bicalutamide + dutasteride in non-metastatic CRPC
ADT + docetaxel and estramustine for high-risk localised prostate cancer
AR-V7 in advanced prostate cancer
Pomegranate extract effects on rising PSA levels
Intraprostatic inflammation association with serum PSA
Resistance training in prostate cancer survivors
Complications after radical prostatectomy or radiotherapy
Immediate vs delayed postoperative radiation for prostate cancer
Please login below to download this issue (PDF)